logo
Health leader condemns ‘black service, not NHS service' received by mother

Health leader condemns ‘black service, not NHS service' received by mother

Leader Live14-06-2025
Lord Victor Adebowale, chairman of the NHS Confederation, described the death of his 92-year-old mother as 'undignified'.
His mother Grace, who worked as an NHS nurse for 45 years, died in January of suspected lung cancer.
But her cancer was not detected until after she died.
Her case highlights systemic racial disparities in healthcare, Lord Adebowale said.
'I just think there are too many situations where people that look like me and shades of me don't get the service,' he said.
In an emotional speech, Lord Adebowale told the NHS ConfedExpo conference in Manchester: 'It was not the dignified death that we would have wanted for her. It wasn't the death she deserved.
'So it makes me clear about the need to address the inequity. I think she got a black service, not an NHS service.
'So I have to address the inequity that still exists within the NHS, in terms of the experiences that people who look like me continue to receive.
'It just hasn't got any better.'
He went on: 'It is not acceptable that someone who looks like me, on average waits 20 minutes longer in A&E than white patients.
'To achieve an inclusive, equitable NHS we need an inclusive equitable culture from top to bottom.'
Mrs Adebowale emigrated from Nigeria to Scotland in the 1950s.
Lord Adebowale, who grew up in Wakefield, said that he did not want to blame anyone, but he said that he wanted to highlight a 'systematic problem'.
'She lived to the age of 92 and you may think, 'well, she had the good old innings', but for a lot of those years she was in some discomfort, and it looks like she died from cancer,' he told reporters.
'It's still the case that if you look like me, you're more likely to discover that you've got cancer in A&E, and that that for me is it's an example of two different services.
'I used the phrase 'black service'… you only have to look at the stats – across all the major disease categories that we talk about, black people have a worse experience and worse outcomes – we've known that for years, I'm not saying anything new.
'My mother is an episodic example of a systematic problem.
'We've got a cancer programme, we've got a cancer we've had targets for diagnostics, and pathways, and yet, people like my mother…'
Lord Adebowale, who established the NHS Race and Health Observatory in 2021 to try and tackle inequalities experienced by black and minority ethnic patients in healthcare, went on: 'I just think there are too many, too many situations where people that look like me and shades of me don't get the service.
'What I'm talking about is a systemic problem exampled by what I have experienced a my mum, and I think she represents a lot of other mums out there and lots of other people out there.'
Asked about his comments about a 'black service', Lord Adebowale went on: 'Why did I (say) it? Because I'm sick of it not changing like everyone else, and I'm close enough to it to know that it happens.
'I could have stood there and give you a load of stats, and you wouldn't be talking to me.
'And my mum, I think, God bless her, I think she would have wanted me to say it.'
He added: 'The disproportionate poor services that too many poor people and too many black people experience, that's what I'm sick of.'
He said there was nothing in his mother's medical records to suggest she had cancer, adding: 'She went to A&E in a poor condition.
'My sister described a hospital that was really struggling when she went in, she had to argue for mum to get a room.
'It was a very busy day. There had to be a negotiation to find a space, which you shouldn't have to do, but that's what happens when people are under pressure.'
He added: 'We haven't got to the bottom of it, and that's why I'm not blaming anybody, and I don't want to, but I can talk about my experience and my observation of what happened to my mum.
'How does that happen? I know it does happen. People have chronic diseases and people don't know and they die of them – I know it's more likely to happen if you're black, it's also more likely to happen if you're poor.
'It's all part of the same story. I used to own story to illustrate a bigger problem, which is systemic.'
On his mother, whose full name was Grace Amoke Owuren Adebowale and who worked in various nursing sectors including mental health, acute care and maternity, he said: 'If you a nurse it is what you are, it's what you're born to do.'
Commenting on Lord Adebowale's remarks, Professor Habib Naqvi, chief executive of the NHS Race and Health Observatory, said: 'We extend our sincere condolences, thoughts and support to Lord Victor and the Adebowale family.
'The loss of a beloved family member is extremely difficult. We thank Victor for the candour in sharing his personal testimony.
'The NHS Race and Health Observatory continues to support healthcare organisations in implementing meaningful change for ethnic minority patients, communities, and members of the healthcare workforce.'Kate Seymour, from the charity Macmillan Cancer Support, said: 'Stories like Grace Amoke Owuren Adebowale's highlight the heartbreaking reality for some when it comes to accessing cancer care in this country.
'It is categorically unacceptable that some people with cancer are having worse experiences simply because of who they are or where they live.'
An NHS spokesperson said: 'Everyone – no matter their background – should receive the best NHS care possible.
'That's why we are working across the NHS to ensure that happens – from improving access to cancer diagnosis and treatment, to expanding health checks for Black and Asian communities and increasing uptake of blood pressure and cholesterol medication in under-served groups.
'But we know there is much more to do, and tackling health inequalities will form an important part of the upcoming 10 Year Health Plan.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

At-home hepatitis C test identifies hundreds with silent but deadly virus
At-home hepatitis C test identifies hundreds with silent but deadly virus

The Independent

time3 minutes ago

  • The Independent

At-home hepatitis C test identifies hundreds with silent but deadly virus

The NHS has identified 225 people with a silent but deadly virus as part of a national drive to stamp out the disease and uncover more victims of the infected blood scandal. The significant discovery was made after more than 100,000 at-home hepatitis C tests were requested since the service's launch in May 2023, including 15,463 in the week after the Infected Blood Inquiry published its final report in May 2024. Hepatitis C - known as a 'silent killer' - is a virus that is passed on through blood-to-blood contact and infects the liver. Some people can live with the virus for many years before realising that they are infected, but the delay in diagnosis can lead to irreparable liver damage, including scarring and cancer. If people test positive, they can often be treated by taking antiviral tablets to fight off the virus for several weeks or offered a test to see whether any damage has been caused to the liver. Health officials said that 105,998 people have ordered an at-home NHS hepatitis C test online since the service was launched in 2023. Among those diagnosed under the NHS scheme so far, NHS England said that seven in 10 are from deprived communities. The most common risk factors reported by positive cases include injecting drug use, sharing needles and other drug paraphernalia and a history of prison. It is understood that only a very small number identified after ordering a test online had a positive result after receiving contaminated blood. In May this year, NHS England also launched a system which means that people of a certain age who newly register with GP practices in England will be asked if they had a blood transfusion prior to 1996 in a bid to find more victims of the infected blood scandal. The Infected Blood Inquiry, which examined the scandal in depth, recommended that the health service should work to 'find the undiagnosed'. More than 30,000 people in the UK were infected with HIV and hepatitis C after they were given contaminated blood and blood products between the 1970s and early 1990s. And more than 3,000 people have died as a result, while survivors are living with lifelong health implications. Professor Meghana Pandit, NHS national medical director, said 'We want to make it easier for people to access care before hidden viruses like hepatitis C cause people serious harm. 'The home testing service is available to everyone, and through targeted outreach to people at higher risk we are helping thousands avoid serious illness and reducing health inequalities in the process. 'If you or someone you know might be at risk, order a free and confidential test today via the NHS hepatitis C testing website – it could save your life.' Early symptoms of hepatitis C NHS Sema Mandal, deputy director for blood safety at UK Health Security Agency, said: 'Our data shows that the number of people with hepatitis C in England is continuing to fall, thanks to more people getting tested and taking treatment that clears the virus. 'I'm delighted to hear that 100,000 of the free self-testing kits have already been ordered via NHS online and this should further help us defeat this disease.' Rachel Halford, chief executive of The Hepatitis C Trust, said: 'Reaching 100,000 home tests is an incredible milestone as we push closer towards the elimination of hepatitis C. 'This option of home testing allows people with any concerns to get a free, confidential test without the need to attend a clinic. For many hesitant to access health services, this can act as a lifeline. 'While injecting drug use remains a key risk factor, it is equally important to remember those affected by the infected blood scandal – the most devastating treatment disaster in the history of the NHS. 'If you received a blood transfusion or blood products before 1996, we strongly encourage you to order a test. Even for peace of mind alone, it could be invaluable. Today's treatments are highly effective, simple to take, and come with minimal side effects.'

Type 2 diabetes patients set for major shake-up in care
Type 2 diabetes patients set for major shake-up in care

Western Telegraph

time25 minutes ago

  • Western Telegraph

Type 2 diabetes patients set for major shake-up in care

The health service should move from a one-size-fits-all approach of starting everyone on the same medication, to more personalised care that aims to prevent complications like heart failure and heart attacks, according to new draft guidance from the National Institute for Health and Care Excellence (Nice). This includes making newer type 2 diabetes drugs, known as SGLT-2 inhibitors, a first-line treatment option in a move that could eventually help save tens of thousands of lives. SGLT-2 inhibitors, which include canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin, are once-a-day tablets that reduce blood sugar levels by helping the kidneys remove glucose, which is passed from the body through urine. However, analysis by Nice found these drugs are under-prescribed. The new guidelines recommend patients who cannot tolerate metformin – the first-choice in type 2 diabetes medication – should start with an SGLT-2 inhibitor on its own. The decision comes after evidence suggested these drugs protect the heart and kidneys as well as controlling blood sugar, Nice said. It is estimated the change could save almost 22,000 lives once uptake reaches 90% of the population. Nice also suggests some groups of patients would also benefit from GLP-1 receptor agonists such as liraglutide or semaglutide sooner, rather than keeping them for the later stages of treatment. Semaglutide, sold under the brand name Ozempic, is licensed in the UK to treat type 2 diabetes, while its other brand – Wegovy – is also used by the NHS to help obese people lose weight. Professor Jonathan Benger, deputy chief executive and chief medical officer at Nice, said: 'This guidance means more people will be offered medicines where it is right to do so to reduce their future risk of ill health. 'This represents a significant evolution in how we approach type 2 diabetes treatment. 'We're moving beyond simply managing blood sugar to taking a holistic view of a person's health, particularly their cardiovascular and kidney health. 'The evidence shows that certain medicines can provide important cardiovascular benefits, and by recommending them as part of initial treatment, we could help prevent heart attacks, strokes and other serious complications before they occur. 'This is particularly important given that cardiovascular disease is the leading cause of death in people with type 2 diabetes.' Around 4.6 million people in the UK are living with diabetes, with nine in 10 of those having type 2. However, it is estimated that a further 1.3 million people may have undiagnosed type 2 diabetes. Nice analysed the records of 590,000 people and found SGLT-2 inhibitors are under-prescribed, particularly to women, older people, and black patients. Prof Benger added: 'The evidence from our analysis is clear. There are prescribing gaps that need to be addressed. 'The guideline update published today will help to increase equitable uptake of SGLT-2 inhibitors, which we know can prevent serious health complications.' Dr Waqaar Shah, chairman of the guideline committee, added: 'We know that SGLT-2 inhibitors are currently under-prescribed, and our health economics analysis shows that people living in the most deprived areas would particularly benefit from universal access to these treatments. 'These recommendations could help reduce health inequalities while providing better outcomes for everyone.' Elsewhere, the draft guidance suggests different treatments for diabetes patients with certain characteristics or health conditions. These include adults with cardiovascular disease, who should be offered a triple therapy including a GLP-1 receptor agonist. Meanwhile, adults diagnosed with type 2 diabetes before 40 should be offered dual therapy before a GLP-1 receptor agonist is considered, while patients with chronic kidney disease should have tailored recommendations based on their kidney function. A public consultation on the new Nice guidelines is open until October 2. Douglas Twenefour, head of clinical at Diabetes UK, said: 'This long-awaited announcement propels type 2 diabetes treatment into the 21st century. 'Boosting access to newer treatments will be transformative for people with type 2 diabetes, while ensuring the UK keeps pace with the global momentum in treating the condition. 'The majority of people with type 2 diabetes are not currently taking the most effective medication for them, putting them at risk of devastating diabetes-related complications. 'Diabetes is a leading cause of cardiovascular disease, and tailoring treatment based on individual risk could protect thousands against heart attacks and kidney disease. 'These guidelines could go a long way to easing the burden of living with this relentless condition, as well as helping to address inequities in type 2 diabetes treatments and outcomes.'

At-home hepatitis C tests identify hundreds with the virus
At-home hepatitis C tests identify hundreds with the virus

Western Telegraph

time25 minutes ago

  • Western Telegraph

At-home hepatitis C tests identify hundreds with the virus

Officials said more than 100,000 people have ordered at-home hepatitis C tests since the service was launched in May 2023. This includes 15,463 tests ordered in the week after the Infected Blood Inquiry published its final report on May 2024. Hepatitis C often shows no signs until serious damage is done. It can be treated, so testing is key to help you help reduce your risk. #WorldHepatitisDay #HepC🔗 — UK Health Security Agency (@UKHSA) July 28, 2025 Hepatitis C is a virus that is passed on through blood-to-blood contact and infects the liver. The disease is known as a 'silent killer' as some people can live with the virus for many years before realising that they are infected. But the delay in diagnosis can lead to irreparable liver damage, including scarring and cancer. If people test positive they can often be treated by taking antiviral tablets to fight off the virus for several weeks. People who test positive may also be offered a test to see whether any damage has been caused to the liver. Health officials said that 105,998 people have ordered an at-home NHS hepatitis C test online since the service was launched in 2023. Among those diagnosed under the NHS scheme so far, NHS England said that seven in 10 are from deprived communities. And it said that the most common risk factors reported by positive cases include injecting drug use, sharing needles and other drug paraphernalia and a history of prison. It is understood that only a very small number identified after ordering a test online had a positive result after receiving contaminated blood. In May this year NHS England also launched a system which means that people of a certain age who newly register with GP practices in England will be asked if they had a blood transfusion prior to 1996 in a bid to find more victims of the infected blood scandal. The Infected Blood Inquiry, which examined the scandal in depth, recommended that the health service should work to 'find the undiagnosed'. More than 30,000 people in the UK were infected with HIV and hepatitis C after they were given contaminated blood and blood products between the 1970s and early 1990s. And more than 3,000 people have died as a result while survivors are living with lifelong health implications. Professor Meghana Pandit, NHS national medical director, said 'We want to make it easier for people to access care before hidden viruses like hepatitis C cause people serious harm. 'The home testing service is available to everyone, and through targeted outreach to people at higher risk we are helping thousands avoid serious illness and reducing health inequalities in the process. 'If you or someone you know might be at risk, order a free and confidential test today via the NHS hepatitis C testing website – it could save your life.' Sema Mandal, deputy director for blood safety at UK Health Security Agency, said: 'Our data shows that the number of people with hepatitis C in England is continuing to fall, thanks to more people getting tested and taking treatment that clears the virus. 'I'm delighted to hear that 100,000 of the free self-testing kits have already been ordered via NHS online and this should further help us defeat this disease.' Rachel Halford, chief executive of The Hepatitis C Trust, said: 'Reaching 100,000 home tests is an incredible milestone as we push closer towards the elimination of hepatitis C. 'This option of home testing allows people with any concerns to get a free, confidential test without the need to attend a clinic. For many hesitant to access health services, this can act as a lifeline. 'While injecting drug use remains a key risk factor, it is equally important to remember those affected by the infected blood scandal – the most devastating treatment disaster in the history of the NHS. 'If you received a blood transfusion or blood products before 1996, we strongly encourage you to order a test. Even for peace of mind alone, it could be invaluable. Today's treatments are highly effective, simple to take, and come with minimal side effects.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store